The first fully A.I.-generated drug enters clinical trials in human patients
Alex Zhavoronkov, left, founder and CEO of Insilico Medicine, and Feng Ren, co-CEO and chief scientific officer, at the company's robotics lab in Suzhou, China.Source: Insilico MedicineThe…